Page last updated: 2024-09-04

lubiprostone and Carcinoma, Anaplastic

lubiprostone has been researched along with Carcinoma, Anaplastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ao, M; Benya, RV; Boonkaewwan, C; Ganesan, N; Rao, MC; Syed, A; Venkatasubramanian, J	1

Other Studies

1 other study(ies) available for lubiprostone and Carcinoma, Anaplastic

Article	Year
Lubiprostone activates Cl- secretion via cAMP signaling and increases membrane CFTR in the human colon carcinoma cell line, T84. Digestive diseases and sciences, 2011, Volume: 56, Issue:2 Topics: Alprostadil; Benzoates; Biological Transport; Bumetanide; Carcinoma; Cathartics; Cell Line, Tumor; Cell Membrane; Chlorides; Colforsin; Colonic Neoplasms; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cystic Fibrosis Transmembrane Conductance Regulator; Dose-Response Relationship, Drug; Gene Expression Regulation; Humans; Lubiprostone; Thiazolidines	2011

Article

Year

Lubiprostone activates Cl- secretion via cAMP signaling and increases membrane CFTR in the human colon carcinoma cell line, T84.

Digestive diseases and sciences, 2011, Volume: 56, Issue:2

Topics: Alprostadil; Benzoates; Biological Transport; Bumetanide; Carcinoma; Cathartics; Cell Line, Tumor; Cell Membrane; Chlorides; Colforsin; Colonic Neoplasms; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cystic Fibrosis Transmembrane Conductance Regulator; Dose-Response Relationship, Drug; Gene Expression Regulation; Humans; Lubiprostone; Thiazolidines

2011